Global Pharmaceutical Product Registration: Process, Requirements & Key Regulatory Markets

Introduction

Bringing a pharmaceutical product to global markets requires more than scientific development—it demands strategic navigation of complex regulatory systems across multiple countries.

Each region follows its own regulatory framework, submission format, and approval pathway. Companies must ensure that their products meet quality, safety, and efficacy standards defined by global regulatory authorities.

At RegOrbis Pharma, we support organizations in achieving efficient, compliant, and successful product registrations worldwide.

 

What is Global Product Registration?

Global product registration is the process of obtaining marketing authorization from regulatory authorities in different countries to legally sell a pharmaceutical product.

It includes:

  • Dossier preparation (CTD/eCTD/ACTD/Region Specific)
  • Submission to health authorities
  • Regulatory review and approval
  • Post-approval lifecycle management

 

Global Registration Process (Step-by-Step)

1️ Regulatory Strategy Development

  • Identify target markets
  • Define submission pathway (generic, NDA, hybrid, etc.)
  • Align with regional guidelines

2️ Dossier Preparation

  • Compilation in CTD/eCTD format
  • Includes:
  • Module 1: Regional/admin
  • Module 2: Summaries
  • Module 3: Quality (CMC)
  • Module 4: Non-clinical
  • Module 5: Clinical / BE

3️ Submission to Regulatory Authority

  • Electronic submission (eCTD or regional format)
  • Validation

4️ Regulatory Review & Queries

  • Scientific assessment
  • Deficiency questions / queries
  • Response submission

5️ Approval / Marketing Authorization

  • Product approved for sale
  • Labeling finalized

6️ Post-Approval Lifecycle Management

  • Variations (Type IA, IB, II)
  • Renewals
  • Pharmacovigilance compliance

 

Key Requirements for Global Registration

High-quality CMC documentation

Validated analytical methods

Stability data (ICH conditions)

Bioequivalence studies (for generics)

GMP compliance for manufacturing sites

Labelling compliance (country-specific)

Risk management and safety data

 

Major Regulatory Agencies & Requirements

United States – US FDA

Submission Types:

  • ANDA (Generic)
  • NDA (New Drug Application)

European Union – EMA

Submission Routes:

  • Centralised Procedure (CP)
  • Decentralised Procedure (DCP)
  • Mutual Recognition Procedure (MRP)
  • National Procedure (NP)

United Kingdom – MHRA

Key Features:

  • Independent regulatory system post-Brexit
  • National MA process

Canada – Health Canada

Submission Types:

  • ANDS (Generic)
  • NDS (Innovator)

Emerging Markets (ASEAN, GCC, AFRICA, CIS)

Submission Types:

  • Country-specific requirements

 

Regulated vs Semi-Regulated Markets

Category

Countries

Characteristics

Regulated Markets

US, EU, UK, Canada, Australia

Strict data, high scrutiny

Semi-Regulated Markets

ASEAN, GCC

Moderate requirements

Emerging Markets

Africa, LATAM

Variable regulations

 

 

 

 

 

 

Key Challenges in Global Registration

1️ Regulatory Diversity – Different requirements across countries

2️ Dossier Customization – Region-specific Module 1 differences

3️ Query Management – Delays in responding to authority questions

4️ Compliance Risk – Data gaps or inconsistency

5️ Timeline Variability – Approval timelines differ significantly

 

Future Trends in Global Regulatory Submissions

  • Full digitalization (eCTD 4.0)
  • Increased global harmonization (ICH)
  • Risk-based regulatory frameworks
  • Faster approvals in emerging markets
  • AI-driven regulatory intelligence

 

How RegOrbis Pharma Supports You

At RegOrbis Pharma, we provide:

  • Global regulatory strategy development
  • Dossier authoring (CTD/eCTD/ACTD/Regional Format)
  • Submission and approval support
  • Health authority query management
  • Lifecycle management (variations, renewals)
  • Market expansion planning

Helping you achieve – Faster approvals | Reduced risk | Global compliance

 

Conclusion

Global pharmaceutical product registration is a strategic and highly regulated process requiring deep expertise and careful planning.

By aligning with global standards and regional requirements, companies can:

  • Accelerate market entry
  • Ensure compliance
  • Expand globally with confidence

 

At RegOrbis Pharma, we simplify global regulatory pathways—helping you bring your products to international markets efficiently, compliantly, and successfully.

 

 

If you need expert support for product registration, our regulatory experts are ready to assist

📧 Email: Info@regorbis.com
📱 Phone: +91 9967265308 / 9668430491

🌐 Website: www.regorbis.com

 

 

Contact us

Connect with RegOrbis for Trusted Global Regulatory Solutions.

Whether you are planning new product registrations, expanding into global markets, managing lifecycle changes, or responding to authority queries, RegOrbis is here to support you at every stage of your regulatory journey.

Your benefits:
What happens next?
1

We Schedule a call at your convenience 

2

We do a discovery and consulting meting 

3

We prepare a proposal 

Schedule a Free Consultation